UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Bioorganic & medicinal chemistry, 2008-02, Vol.18 (3), p.923-928

2008

Volltextzugriff (PDF)

Involvement of αvβ3 integrins in osteoclast function

Journal of bone and mineral metabolism, 2007-11, Vol.25 (6), p.337-344

2007

Volltextzugriff (PDF)

The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats

Endocrinology (Philadelphia), 1998-03, Vol.139 (3), p.1411-1419

1998

Volltextzugriff (PDF)

Identification of a potent and selective non-basic cathepsin K inhibitor

Bioorganic & medicinal chemistry letters, 2006-04, Vol.16 (7), p.1985-1989

2006

Volltextzugriff (PDF)

A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K

Journal of medicinal chemistry, 2003-08, Vol.46 (17), p.3709-3727

2003

Volltextzugriff (PDF)

Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L

Journal of medicinal chemistry, 2001-01, Vol.44 (1), p.94-104

2001

Volltextzugriff (PDF)

The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (3), p.887-892

2010

Volltextzugriff (PDF)

Nonpeptide αvβ3 Antagonists. 8. In Vitro and in Vivo Evaluation of a Potent αvβ3 Antagonist for the Prevention and Treatment of Osteoporosis

Journal of medicinal chemistry, 2003-10, Vol.46 (22), p.4790-4798

2003

Volltextzugriff (PDF)

Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in vivo and in vitro

Science (American Association for the Advancement of Science), 1987-12, Vol.238 (4833), p.1566-1568

1987

Volltextzugriff (PDF)

Binding Model for Nonpeptide Antagonists of αvβ3 Integrin

Journal of medicinal chemistry, 2002-12, Vol.45 (26), p.5640-5648

2002

Volltextzugriff (PDF)

Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitors

Bioorganic & medicinal chemistry letters, 2004-08, Vol.14 (16), p.4291-4295

2004

Volltextzugriff (PDF)

Nonpeptide αvβ3 antagonists. Part 2: Constrained glycyl amides derived from the RGD tripeptide

Bioorganic & medicinal chemistry letters, 2002-01, Vol.12 (1), p.25-29

2002

Volltextzugriff (PDF)

Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties

Cancer research (Chicago, Ill.), 1987-09, Vol.47 (18), p.4961-4966

1987

Volltextzugriff (PDF)

Non-peptide αvβ3 antagonists. Part 7: 3-Substituted tetrahydro-[1,8]naphthyridine derivatives

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.1049-1052

2004

Volltextzugriff (PDF)

Nonpeptide αvβ3 antagonists : identification of potent, chain-shortened 7-oxo RGD mimetics

Bioorganic & medicinal chemistry letters, 2005-03, Vol.15 (6), p.1647-1650

2005

Volltextzugriff (PDF)

Sphingosine Kinase Mediates Cyclic AMP Suppression of Apoptosis in Rat Periosteal Cells

Molecular pharmacology, 1998-07, Vol.54 (1), p.70-77

1998

Volltextzugriff (PDF)

Non-peptide αvβ3 antagonists: Identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraint

Bioorganic & medicinal chemistry letters, 2003-12, Vol.13 (24), p.4285-4288

2003

Volltextzugriff (PDF)

Nonpeptide αvβ3 antagonists. Part 10: in vitro and in vivo evaluation of a potent 7-methyl substituted tetrahydro-[1,8]naphthyridine derivative

Bioorganic & medicinal chemistry letters, 2004-09, Vol.14 (17), p.4515-4518

2004

Volltextzugriff (PDF)

Non-peptide αvβ3 antagonists. Part 5: Identification of potent rgd mimetics incorporating 2-aryl β-amino acids as aspartic acid replacements

Bioorganic & medicinal chemistry letters, 2002-12, Vol.12 (23), p.3483-3486

2002

Volltextzugriff (PDF)

Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitors

Bioorganic & medicinal chemistry, 2002-10, Vol.10 (10), p.3277-3284

2002

Volltextzugriff (PDF)

Nonpeptide α vβ 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backbone

Bioorganic & medicinal chemistry letters, 2004-09, Vol.14 (17), p.4411-4415

2004

Volltextzugriff (PDF)

Non-peptide αvβ3 antagonists. Part 3: Identification of potent RGD mimetics incorporating novel β-amino acids as aspartic acid replacements

Bioorganic & medicinal chemistry letters, 2002-01, Vol.12 (1), p.31-34

2002

Volltextzugriff (PDF)

Isolation and Characterization of Highly Enriched, Prefusion Mouse Osteoclastic Cells

Experimental cell research, 1995-08, Vol.219 (2), p.679-686

1995

Volltextzugriff (PDF)

Nonpeptide αvβ3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backbone

Bioorganic & medicinal chemistry letters, 2004-09, Vol.14 (17), p.4411-4415

2004

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(95)
Buchkapitel
(2)

Sprache

Englisch
(97)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Animals
(41)
Science & Technology
(31)
Biological And Medical Sciences
(30)
Life Sciences & Biomedicine
(30)
Medical Sciences
(25)
Rats
(24)
Pharmacology. Drug Treatments
(21)
Humans
(19)
Bones, Joints And Connective Tissue. Antiinflammatory Agents
(17)
Pharmacology & Pharmacy
(14)
Structure-Activity Relationship
(14)
Chemistry, Medicinal
(13)
Adenylyl Cyclases - Metabolism
(11)
Dogs
(10)
Chemistry
(9)
Chemistry, Organic
(9)
Female
(9)
Parathyroid Hormone - Pharmacology
(9)
Physical Sciences
(9)
Cell Line
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Involvement of αvβ3 integrins in osteoclast function

The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats

Identification of a potent and selective non-basic cathepsin K inhibitor

A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K

Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L

The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor

Nonpeptide αvβ3 Antagonists. 8. In Vitro and in Vivo Evaluation of a Potent αvβ3 Antagonist for the Prevention and Treatment of Osteoporosis

Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in vivo and in vitro

Binding Model for Nonpeptide Antagonists of αvβ3 Integrin

Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitors

Nonpeptide αvβ3 antagonists. Part 2: Constrained glycyl amides derived from the RGD tripeptide

Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties

Non-peptide αvβ3 antagonists. Part 7: 3-Substituted tetrahydro-[1,8]naphthyridine derivatives

Nonpeptide αvβ3 antagonists : identification of potent, chain-shortened 7-oxo RGD mimetics

Sphingosine Kinase Mediates Cyclic AMP Suppression of Apoptosis in Rat Periosteal Cells

Non-peptide αvβ3 antagonists: Identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraint

Nonpeptide αvβ3 antagonists. Part 10: in vitro and in vivo evaluation of a potent 7-methyl substituted tetrahydro-[1,8]naphthyridine derivative

Non-peptide αvβ3 antagonists. Part 5: Identification of potent rgd mimetics incorporating 2-aryl β-amino acids as aspartic acid replacements

Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitors

Nonpeptide α vβ 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backbone

Non-peptide αvβ3 antagonists. Part 3: Identification of potent RGD mimetics incorporating novel β-amino acids as aspartic acid replacements

Isolation and Characterization of Highly Enriched, Prefusion Mouse Osteoclastic Cells

Design and Synthesis of Tri-Ring P3 Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin K

Nonpeptide αvβ3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backbone

Suchergebnisse filtern